TRxADE Health Inc
NASDAQ:MEDS
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is MEDS's stock price target?
Not Available
MEDS doesn't have any price targets made by Wall Street professionals.
What is TRxADE Health Inc's Revenue forecast?
Projected CAGR
15%
For the last 8 years the
compound annual growth rate for
TRxADE Health Inc's revenue is
14%.
The projected
CAGR
for the next 1 year is
15%.